The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation

被引:246
作者
Hansen, Guido [2 ]
Hercus, Timothy R. [1 ]
McClure, Barbara J. [1 ]
Stomski, Frank C. [1 ]
Dottore, Mara [1 ]
Powell, Jason [1 ]
Ramshaw, Hayley [1 ]
Woodcock, Joanna M. [1 ]
Xu, Yibin [2 ]
Guthridge, Mark [1 ]
McKinstry, William J. [2 ]
Lopez, Angel F. [1 ]
Parker, Michael W. [2 ,3 ]
机构
[1] Hanson Inst, Inst Med & Vet Sci, Div Human Immunol, Adelaide, SA 5000, Australia
[2] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia
[3] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia
基金
美国国家卫生研究院; 澳大利亚研究理事会; 英国医学研究理事会;
关键词
D O I
10.1016/j.cell.2008.05.053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic cytokine that controls the production and function of blood cells, is deregulated in clinical conditions such as rheumatoid arthritis and leukemia, yet offers therapeutic value for other diseases. Its receptors are heterodimers consisting of a ligand-specific a subunit and a beta c subunit that is shared with the interleukin (IL)-3 and IL-5 receptors. How signaling is initiated remains an enigma. We report here the crystal structure of the human GM-CSF/GM-CSF receptor ternary complex and its assembly into an unexpected dodecamer or higher-order complex. Importantly, mutagenesis of the GM-CSF receptor at the dodecamer interface and functional studies reveal that dodecamer formation is required for receptor activation and signaling. This unusual form of receptor assembly likely applies also to IL-3 and IL-5 receptors, providing a structural basis for understanding their mechanism of activation and for the development of therapeutics.
引用
收藏
页码:496 / 507
页数:12
相关论文
共 54 条
[31]   The beta subunit of human granulocyte-macrophage colony-stimulating factor receptor forms a homodimer and is activated via association with the alpha subunit [J].
Muto, A ;
Watanabe, S ;
Miyajima, A ;
Yokota, T ;
Arai, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1911-1916
[32]   Jak2 is essential for signaling through a variety of cytokine receptors [J].
Parganas, E ;
Wang, D ;
Stravopodis, D ;
Topham, DJ ;
Marine, JC ;
Teglund, S ;
Vanin, EF ;
Bodner, S ;
Colamonici, OR ;
van Deursen, JM ;
Grosveld, G ;
Ihle, JN .
CELL, 1998, 93 (03) :385-395
[33]   JAK2 ASSOCIATES WITH THE BETA(C) CHAIN OF THE RECEPTOR FAR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, AND ITS ACTIVATION REQUIRES THE MEMBRANE-PROXIMAL REGION [J].
QUELLE, FW ;
SATO, N ;
WITTHUHN, BS ;
INHORN, RC ;
EDER, M ;
MIYAJIMA, A ;
GRIFFIN, JD ;
IHLE, JN .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4335-4341
[34]   Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition [J].
Rajotte, D ;
Cadieux, C ;
Haman, A ;
Wilkes, BC ;
Clark, SC ;
Hercus, T ;
Woodcock, JA ;
Lopez, A ;
Hoang, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (11) :1939-1950
[35]   Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivo [J].
Ramshaw, HS ;
Bardy, PG ;
Lee, MA ;
Lopez, AF .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (10) :1124-1131
[36]   The JAK/STAT signaling pathway [J].
Rawlings, JS ;
Rosler, KM ;
Harrison, DA .
JOURNAL OF CELL SCIENCE, 2004, 117 (08) :1281-1283
[37]  
Rossjohn J, 2000, BLOOD, V95, P2491
[38]  
Rozwarski DA, 1996, PROTEINS, V26, P304, DOI 10.1002/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO
[39]  
2-D
[40]   CRITICAL CYTOPLASMIC DOMAINS OF THE COMMON BETA-SUBUNIT OF THE HUMAN GM-CSF, IL-3 AND IL-5 RECEPTORS FOR GROWTH SIGNAL TRANSDUCTION AND TYROSINE PHOSPHORYLATION [J].
SAKAMAKI, K ;
MIYAJIMA, I ;
KITAMURA, T ;
MIYAJIMA, A .
EMBO JOURNAL, 1992, 11 (10) :3541-3549